The Europe medical cannabis market was valued at USD 2,167.8 million in 2023. According to IMARC Group, it is projected to grow to USD 11,093.7 million by 2032, expanding at a compound annual growth rate (CAGR) of 19.3% from 2024 to 2032. This growth is driven by increasing legalization, expanding therapeutic uses, and rising patient demand. Advancements in cultivation and extraction ... https://www.imarcgroup.com/europe-medical-cannabis-market